AMA, AHA Call For Drug Pricing Transparency, Increased Competition

Representatives from the American Medical Association and the American Hospital Association called for increased drug pricing transparency and reduced regulations to increase competition at a panel on Monday (Sept. 25) on the cost of drugs at America's Health Insurance Plans' Medicare conference. AMA Senior Vice President for Advocacy Richard Deem said that not much will change when it comes to rising costs until the industry achieves transparency in drug pricing. "Physicians should be subject to transparency in terms to prices...